Antibiotice S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was RON 13.38 million compared to RON 13.78 million a year ago. Net income was RON 80.69 million compared to RON 38.51 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.96 RON | +2.08% | +2.62% | +40.50% |
1st Jan change | Capi. | |
---|---|---|
+40.50% | 288M | |
+31.89% | 694B | |
+29.31% | 593B | |
-1.71% | 371B | |
+19.62% | 331B | |
+6.74% | 290B | |
+14.26% | 239B | |
-3.15% | 209B | |
+10.03% | 209B | |
+8.21% | 169B |
- Stock Market
- Equities
- ATB Stock
- News Antibiotice S.A.
- Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023